Merck (MRK) Free Cash Flow (2009 - 2026)

Merck (MRK) has 18 years of Free Cash Flow data on file, last reported at $2.9 billion in Q1 2026.

• Free Cash Flow for Q1 2026 came in at $2.9 billion, up 149.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.1 billion (down 17.16% YoY), and the FY2025 annual result was $12.4 billion, down 31.7% from the prior year.
• Free Cash Flow advanced to $2.9 billion in Q1 2026 per MRK's latest filing, from $1.8 billion in the prior quarter.
• Over five years, Free Cash Flow peaked at $8.5 billion in Q3 2024 and troughed at -$743.0 million in Q4 2023.
• A 5-year average of $3.4 billion and a median of $2.9 billion in 2026 frame the typical range for Free Cash Flow.
• The sharpest annual moves came in 2022 and 2023: Free Cash Flow jumped 2290.51% in 2022, then slumped 122.65% in 2023.
• A 5-year view of Free Cash Flow shows it stood at $3.3 billion in 2022, then tumbled by 122.65% to -$743.0 million in 2023, then jumped by 438.22% to $2.5 billion in 2024, then fell by 27.42% to $1.8 billion in 2025, then surged by 60.47% to $2.9 billion in 2026.
• Business Quant data shows MRK's Free Cash Flow at $2.9 billion in Q1 2026, $1.8 billion in Q4 2025, and $6.8 billion in Q3 2025.